Press releases
07-27-2010
curasan AG scouts for sales partners for ATR®
Kleinostheim, Germany, 27th July 2010 – curasan AG, listed in the General Standard of the Frankfurt Stock Exchange (ISIN: DE 000 549 453 8), has commenced with the pre-marketing activities for the launch of its new product ATR® (Advanced Tissue Regeneration)...
05-25-2010
curasan AG: cooperation agreement for new product line
Kleinostheim, Germany, 25th May 2010 – curasan AG, listed in the General Standard of the Frankfurt Stock Exchange (ISIN: DE 000 549 453 8), has concluded a contract with Matricel GmbH, Herzogenrath, which secures exclusive rights for both companies over a jointly developed new product line...
05-06-2010
curasan AG: 2009 fiscal year above expectations
Kleinostheim, Germany, 6th May 2010 – curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), was able to achieve an annual surplus of 0.2 million Euro in the fiscal year 2009 ...
04-28-2010
curasan AG: One million units of Cerasorb® produced
Kleinostheim, Germany, 28th April 2010 – The employees of curasan AG awaited the recently produced batch of Cerasorb® M with particular excitement – because amongst this batch was the one millionth bottle ready for sale...
02-18-2010
curasan AG: New US subsidiary for orthopaedics
Kleinostheim, Germany, 18th February 2010 – curasan AG, listed in the General Standard of the Deutsche Börse AG (ISIN: DE 000 549 453 8), is commencing the sale, through a subsidiary, of its synthetic bone regeneration material Cerasorb® M Ortho in the United States ...
12-09-2009
curasan AG receives license for Osbone®
Kleinostheim, Germany, 9th December 2009 - curasan AG, which is listed in General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has received CE certification and, therefore, marketing authorization throughout Europe of the synthetic bone replacement material Osbone®...
11-16-2009
curasan AG signs a research agreement with Ben-Gurion University
Kleinostheim, Germany, 16th November 2009 – curasan AG, which is listed on the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has signed a research and development agreement with the Ben-Gurion University of the Negev (BGU), Israel...
10-15-2009
curasan AG received licence for ATR®
Kleinostheim, Germany, 15 October 2009 – curasan AG, which is listed on the
General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8),
has been received CE certification and, therefore, marketing authorization for
the ATR® (Advanced Tissue Regeneration) product...
12-11-2007
Curasan AG: US-Subsidiary on the road to Success
curasan Inc., Research Triangle Park, North Carolina, USA, wholly owned subsidiary of curasan AG, Kleinostheim, is ahead of its business development schedule and is near a break-even point as 2007 closes...